Faslodex (fulvestrant), a new drug for metastatic breast cancer
You'll start hearing about Faslodex (fulvestrant), a new drug for metastatic breast cancer.
It's awaiting approval in Canada...and just became available in the U.S.
Faslodex is a once-monthly injection to treat postmenopausal women whose cancer progresses on tamoxifen or another antiestrogen.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote